Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7325482 | Journal of Psychosomatic Research | 2018 | 8 Pages |
Abstract
Symptoms of depression and anxiety are highly prevalent in stable CHD patients, and their long-term trajectories are the single biggest driver of health care costs. Managing morbidity in these patients, in which depression and anxiety play a key role in, should become the primary focus of policy makers and future clinical trials.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Jorge Palacios, Mizanur Khondoker, Anthony Mann, Andre Tylee, Matthew Hotopf,